The Oncosearch | Oncotarget

Multimodal imaging guided preclinical trials of vascular targeting in prostate cancer Research Paper

James Kalmuk, Margaret Folaron, Julian Buchinger, Roberto Pili, Mukund Seshadri

Published Jul 2, 2015 · Vol. 6, No. 27 · pp. 24376-24392

Prognostic impact of c-Rel nuclear expression and REL amplification and crosstalk between c-Rel and the p53 pathway in diffuse large B-cell lymphoma Priority Research Paper

Ling Li, Zijun Y. Xu-Monette, Chi Young Ok, Alexandar Tzankov, Ganiraju C. Manyam, Ruifan Sun, Carlo Visco, Mingzhi Zhang, Santiago Montes-Moreno, Karen Dybkaer, April Chiu, Attilio Orazi, Youli Zu, Govind Bhagat, Kristy L. Richards, Eric D. Hsi, William W.L. Choi, J. Han van Krieken, Jooryung Huh, Maurilio Ponzoni, AndrÃ©s J.M. Ferreri, Michael B. MÃ¸ller, Jinfeng Wang, Ben M. Parsons, Jane N. Winter, Miguel A. Piris, Lan V. Pham, L. Jeffrey Medeiros, Ken H. Young

Published Jun 30, 2015 · Vol. 6, No. 27 · pp. 23157-23180

A MEK/PI3K/HDAC inhibitor combination therapy for KRAS mutant pancreatic cancer cells Priority Research Paper

Irene Ischenko, Oleksi Petrenko, Michael J. Hayman

Published Jun 19, 2015 · Vol. 6, No. 18 · pp. 15814-15827

Hyperglycemia-induced metabolic compensation inhibits metformin sensitivity in ovarian cancer Research Paper

Lacey M. Litchfield, Abir Mukherjee, Mark A. Eckert, Alyssa Johnson, Kathryn A. Mills, Shawn Pan, Viji Shridhar, Ernst Lengyel, Iris L. Romero

Published Jun 19, 2015 · Vol. 6, No. 27 · pp. 23548-23560

Chemokines CCL2, 3, 14 stimulate macrophage bone marrow homing, proliferation, and polarization in multiple myeloma Research Paper

Yi Li, Yuhuan Zheng, Tianshu Li, Qiang Wang, Jianfei Qian, Yong Lu, Mingjun Zhang, Enguang Bi, Maojie Yang, Frederic Reu, Qing Yi, Zhen Cai

Published Jun 19, 2015 · Vol. 6, No. 27 · pp. 24218-24229

YM155, a survivin suppressant, triggers PARP-dependent cell death (parthanatos) and inhibits esophageal squamous-cell carcinoma xenografts in mice Research Paper

Nan Zhao, Yousheng Mao, Gaijing Han, Qiang Ju, Lanping Zhou, Fang Liu, Yang Xu, Xiaohang Zhao

Published Jun 15, 2015 · Vol. 6, No. 21 · pp. 18445-18459

Long noncoding RNAs and neuroblastoma Review

Gaurav Kumar Pandey, Chandrasekhar Kanduri

Published Jun 10, 2015 · Vol. 6, No. 21 · pp. 18265-18275

Gene expression profiling signatures for the diagnosis and prevention of oral cavity carcinogenesis-genome-wide analysis using RNA-seq technology Research Paper

Xiao-Han Tang, Alison M. Urvalek, Kwame Osei-Sarfo, Tuo Zhang, Theresa Scognamiglio, Lorraine J. Gudas

Published Jun 10, 2015 · Vol. 6, No. 27 · pp. 24424-24435

MUC16-mediated activation of mTOR and c-Myc reprograms pancreatic cancer metabolism Research Paper

Surendra K. Shukla, Venugopal Gunda, Jaime Abrego, Dhanya Haridas, Anusha Mishra, Joshua Souchek, Nina V. Chaika, Fang Yu, Aaron R. Sasson, Audrey J. Lazenby, Surinder K. Batra, Pankaj K. Singh

Published Jun 3, 2015 · Vol. 6, No. 22 · pp. 19118-19131

MYC amplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy Research Paper

Toril Holien, Kristine Misund, Oddrun Elise Olsen, Katarzyna Anna Baranowska, Glenn Buene, Magne BÃ¸rset, Anders Waage, Anders Sundan

Published Jun 2, 2015 · Vol. 6, No. 26 · pp. 22698-22705

Structurally diverse c-Myc inhibitors share a common mechanism of action involving ATP depletion Priority Research Paper

Huabo Wang, Lokendra Sharma, Jie Lu, Paul Finch, Steven Fletcher, Edward V. Prochownik

Published May 30, 2015 · Vol. 6, No. 18 · pp. 15857-15870

MYC or BCL2 copy number aberration is a strong predictor of outcome in patients with diffuse large B-cell lymphoma Research Paper

Ting-Xun Lu, Lei Fan, Li Wang, Jia-Zhu Wu, Kou-Rong Miao, Jin-Hua Liang, Qi-Xing Gong, Zhen Wang, Ken H. Young, Wei Xu, Zhi-Hong Zhang, Jian-Yong Li

Published May 29, 2015 · Vol. 6, No. 21 · pp. 18374-18388

Identification of alsterpaullone as a novel small molecule inhibitor to target group 3 medulloblastoma Research Paper

Claudia C. Faria, Sameer Agnihotri, Stephen C. Mack, Brian J. Golbourn, Roberto J. Diaz, Samantha Olsen, Melissa Bryant, Matthew Bebenek, Xin Wang, Kelsey C. Bertrand, Michelle Kushida, Renee Head, Ian Clark, Peter Dirks, Christian A. Smith, Michael D. Taylor, James T. Rutka

Published May 28, 2015 · Vol. 6, No. 25 · pp. 21718-21729

MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma Research Paper

Jia-Yuan Huang, Kai Zhang, Dong-Qin Chen, Jing Chen, Bing Feng, Haizhu Song, Yitian Chen, Ziman Zhu, Lei Lu, Wei De, Rui Wang, Long-Bang Chen

Published May 27, 2015 · Vol. 6, No. 21 · pp. 18613-18630

Ataxia-telangiectasia mutated (ATM) silencing promotes neuroblastoma progression through a MYCN independent mechanism Research Paper

Stefano J. Mandriota, Linda J. Valentijn, Laurence Lesne, David R. Betts, Denis Marino, Mary Boudal-Khoshbeen, Wendy B. London, Anne-Laure Rougemont, Edward F. Attiyeh, John M. Maris, Michael D. Hogarty, Jan Koster, Jan J. Molenaar, Rogier Versteeg, Marc Ansari, Fabienne Gumy-Pause

Published May 26, 2015 · Vol. 6, No. 21 · pp. 18558-18576

Analysis of the transcriptional regulation of cancer-related genes by aberrant DNA methylation of the cis-regulation sites in the promoter region during hepatocyte carcinogenesis caused by arsenic Research Paper

Zhuang Miao, Lin Wu, Ming Lu, Xianzhi Meng, Bo Gao, Xin Qiao, Weihui Zhang, Dongbo Xue

Published May 25, 2015 · Vol. 6, No. 25 · pp. 21493-21506

NDRG4 is a novel oncogenic protein and p53 associated regulator of apoptosis in malignant meningioma cells Research Paper

Rama P. Kotipatruni, Xuan Ren, Dinesh Thotala, Jerry J. Jaboin

Published May 25, 2015 · Vol. 6, No. 19 · pp. 17594-17604

TMEM196 acts as a novel functional tumour suppressor inactivated by DNA methylation and is a potential prognostic biomarker in lung cancer Research Paper

Wen-bin Liu, Fei Han, Xiao Jiang, Hong-qiang Chen, Huan Zhao, Yong Liu, Yong-hong Li, Chuanshu Huang, Jia Cao, Jin-yi Liu

Published May 22, 2015 · Vol. 6, No. 25 · pp. 21225-21239

Small molecule inhibitor screen identifies synergistic activity of the bromodomain inhibitor CPI203 and bortezomib in drug resistant myeloma Research Paper

Matthew B. Siegel, Selina Qiuying Liu, Monika A. Davare, Stephen E. Spurgeon, Marc M. Loriaux, Brian J. Druker, Emma C. Scott, Jeffrey W. Tyner

Published May 20, 2015 · Vol. 6, No. 22 · pp. 18921-18932

Novel HER3/MUC4 oncogenic signaling aggravates the tumorigenic phenotypes of pancreatic cancer cells Research Paper

Imayavaramban Lakshmanan, Parthasarathy Seshacharyulu, Dhanya Haridas, Satyanarayana Rachagani, Suprit Gupta, Suhasini Joshi, Chittibabu Guda, Ying Yan, Maneesh Jain, Apar K. Ganti, Moorthy P. Ponnusamy, Surinder K. Batra

Published May 16, 2015 · Vol. 6, No. 25 · pp. 21085-21099

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Multimodal imaging guided preclinical trials of vascular targeting in prostate cancer Research Paper

Prognostic impact of c-Rel nuclear expression and REL amplification and crosstalk between c-Rel and the p53 pathway in diffuse large B-cell lymphoma Priority Research Paper

A MEK/PI3K/HDAC inhibitor combination therapy for KRAS mutant pancreatic cancer cells Priority Research Paper

Hyperglycemia-induced metabolic compensation inhibits metformin sensitivity in ovarian cancer Research Paper

Chemokines CCL2, 3, 14 stimulate macrophage bone marrow homing, proliferation, and polarization in multiple myeloma Research Paper

YM155, a survivin suppressant, triggers PARP-dependent cell death (parthanatos) and inhibits esophageal squamous-cell carcinoma xenografts in mice Research Paper

Long noncoding RNAs and neuroblastoma Review

Gene expression profiling signatures for the diagnosis and prevention of oral cavity carcinogenesis-genome-wide analysis using RNA-seq technology Research Paper

MUC16-mediated activation of mTOR and c-Myc reprograms pancreatic cancer metabolism Research Paper

MYC amplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy Research Paper

Structurally diverse c-Myc inhibitors share a common mechanism of action involving ATP depletion Priority Research Paper

MYC or BCL2 copy number aberration is a strong predictor of outcome in patients with diffuse large B-cell lymphoma Research Paper

Identification of alsterpaullone as a novel small molecule inhibitor to target group 3 medulloblastoma Research Paper

MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma Research Paper

Ataxia-telangiectasia mutated (ATM) silencing promotes neuroblastoma progression through a MYCN independent mechanism Research Paper

Analysis of the transcriptional regulation of cancer-related genes by aberrant DNA methylation of the cis-regulation sites in the promoter region during hepatocyte carcinogenesis caused by arsenic Research Paper

NDRG4 is a novel oncogenic protein and p53 associated regulator of apoptosis in malignant meningioma cells Research Paper

TMEM196 acts as a novel functional tumour suppressor inactivated by DNA methylation and is a potential prognostic biomarker in lung cancer Research Paper

Small molecule inhibitor screen identifies synergistic activity of the bromodomain inhibitor CPI203 and bortezomib in drug resistant myeloma Research Paper

Novel HER3/MUC4 oncogenic signaling aggravates the tumorigenic phenotypes of pancreatic cancer cells Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Multimodal imaging guided preclinical trials of vascular targeting in prostate cancer Research Paper

Prognostic impact of c-Rel nuclear expression and REL amplification and crosstalk between c-Rel and the p53 pathway in diffuse large B-cell lymphoma Priority Research Paper

A MEK/PI3K/HDAC inhibitor combination therapy for KRAS mutant pancreatic cancer cells Priority Research Paper

Hyperglycemia-induced metabolic compensation inhibits metformin sensitivity in ovarian cancer Research Paper

Chemokines CCL2, 3, 14 stimulate macrophage bone marrow homing, proliferation, and polarization in multiple myeloma Research Paper

YM155, a survivin suppressant, triggers PARP-dependent cell death (parthanatos) and inhibits esophageal squamous-cell carcinoma xenografts in mice Research Paper

Long noncoding RNAs and neuroblastoma Review

Gene expression profiling signatures for the diagnosis and prevention of oral cavity carcinogenesis-genome-wide analysis using RNA-seq technology Research Paper

MUC16-mediated activation of mTOR and c-Myc reprograms pancreatic cancer metabolism Research Paper

MYC amplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy Research Paper

Structurally diverse c-Myc inhibitors share a common mechanism of action involving ATP depletion Priority Research Paper

MYC or BCL2 copy number aberration is a strong predictor of outcome in patients with diffuse large B-cell lymphoma Research Paper

Identification of alsterpaullone as a novel small molecule inhibitor to target group 3 medulloblastoma Research Paper

MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma Research Paper

Ataxia-telangiectasia mutated (ATM) silencing promotes neuroblastoma progression through a MYCN independent mechanism Research Paper

Analysis of the transcriptional regulation of cancer-related genes by aberrant DNA methylation of the cis-regulation sites in the promoter region during hepatocyte carcinogenesis caused by arsenic Research Paper

NDRG4 is a novel oncogenic protein and p53 associated regulator of apoptosis in malignant meningioma cells Research Paper

TMEM196 acts as a novel functional tumour suppressor inactivated by DNA methylation and is a potential prognostic biomarker in lung cancer Research Paper

Small molecule inhibitor screen identifies synergistic activity of the bromodomain inhibitor CPI203 and bortezomib in drug resistant myeloma Research Paper

Novel HER3/MUC4 oncogenic signaling aggravates the tumorigenic phenotypes of pancreatic cancer cells Research Paper